Cristina Drugan - Search Results

Year	Number of Results
2002	2
2009	1
2010	1
2012	2
2013	1
2016	3
2017	3
2019	1
2020	1
2021	3
2022	2

1

The Pattern of Calculated Inflammation Ratios as Prognostic Values in Patients with Colorectal Cancer.

Ciocan A, Bolboacă SD, Drugan C, Ciocan RA, Graur F, Al Hajjar N. Ciocan A, et al. Among authors: drugan c. Comb Chem High Throughput Screen. 2021;24(9):1428-1435. doi: 10.2174/1386207323666201020111946. Comb Chem High Throughput Screen. 2021. PMID: 33081678

2

Evaluation of Circulating Chitotriosidase Activity in Children with Obesity.

Țaranu I, Iancu M, Lazea C, Alkhzouz C, Răcătăianu N, Cătană CS, Mirea AM, Miclea D, Bolboacă SD, Drugan C. Țaranu I, et al. Among authors: drugan c. J Clin Med. 2022 Jun 23;11(13):3634. doi: 10.3390/jcm11133634. J Clin Med. 2022. PMID: 35806923 Free PMC article.

3

Evaluation of Chitotriosidase and Neopterin as Biomarkers of Microvascular Complications in Patients with Type 1 Diabetes Mellitus.

Cutaș A, Drugan C, Roman G, Rusu A, Cătană CS, Achimaș-Cadariu A, Drugan T. Cutaș A, et al. Among authors: drugan c. Diagnostics (Basel). 2021 Feb 8;11(2):263. doi: 10.3390/diagnostics11020263. Diagnostics (Basel). 2021. PMID: 33567717 Free PMC article.

4

Modelling long-term evolution of chitotriosidase in non-neuronopathic Gaucher disease.

Drugan C, Drugan TC, Grigorescu-Sido P, Naşcu I. Drugan C, et al. Scand J Clin Lab Invest. 2017 Jul;77(4):275-282. doi: 10.1080/00365513.2017.1303191. Epub 2017 Mar 20. Scand J Clin Lab Invest. 2017. PMID: 28319420

5

Evaluation of several serum interleukins as markers for treatment effectiveness in naïve HIV infected patients: A pilot study.

Jianu C, Itu-Mureşan C, Drugan C, Filipescu I, Topan AV, Jianu ME, Morar II, Bolboacă SD. Jianu C, et al. Among authors: drugan c. PLoS One. 2021 Nov 16;16(11):e0260007. doi: 10.1371/journal.pone.0260007. eCollection 2021. PLoS One. 2021. PMID: 34784398 Free PMC article.

6

Evaluation of neopterin as a biomarker for the monitoring of Gaucher disease patients.

Drugan C, Drugan TC, Miron N, Grigorescu-Sido P, Naşcu I, Cătană C. Drugan C, et al. Hematology. 2016 Jul;21(6):379-86. doi: 10.1080/10245332.2016.1144336. Epub 2016 Feb 24. Hematology. 2016. PMID: 26903266

7

The association between interleukin-10 (IL-10) -592C/A, -819T/C, -1082G/A promoter polymorphisms and endometriosis.

Malutan AM, Drugan C, Walch K, Drugan T, Ciortea R, Mihu D. Malutan AM, et al. Among authors: drugan c. Arch Gynecol Obstet. 2017 Feb;295(2):503-510. doi: 10.1007/s00404-016-4269-5. Epub 2016 Dec 21. Arch Gynecol Obstet. 2017. PMID: 28004192

8

Evaluation of Chitotriosidase as a Marker of Inflammatory Status in Critical Limb Ischemia.

Ciocan RA, Drugan C, Gherman CD, Cătană CS, Ciocan A, Drugan TC, Bolboacă SD. Ciocan RA, et al. Among authors: drugan c. Ann Clin Lab Sci. 2017 Nov;47(6):713-719. Ann Clin Lab Sci. 2017. PMID: 29263045

9

Assessment of Specific Tumoral Markers, Inflammatory Status, and Vitamin D Metabolism before and after the First Chemotherapy Cycle in Patients with Lung Cancer.

Crintea A, Drugan C, Constantin AM, Lupan I, Fekete Z, Silaghi CN, Crăciun AM. Crintea A, et al. Among authors: drugan c. Biology (Basel). 2022 Jul 8;11(7):1033. doi: 10.3390/biology11071033. Biology (Basel). 2022. PMID: 36101414 Free PMC article.

10

The association between interleukin-4 -590C/T genetic polymorphism, IL-4 serum level, and advanced endometriosis.

Malutan AM, Drugan C, Drugan T, Ciortea R, Mihu D. Malutan AM, et al. Among authors: drugan c. Cent Eur J Immunol. 2016;41(2):176-81. doi: 10.5114/ceji.2016.60992. Epub 2016 Jul 15. Cent Eur J Immunol. 2016. PMID: 27536203 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results